Numerai’s AtriCure ATRC Stock Holding History

Numerai’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,610	Closed	-$375K	–	464
2025 Q1	$375K	Buy	+11,610	New	+$431K	0.07%	342
2023 Q2	–	Sell	-36,901	Closed	-$1.53M	–	168
2023 Q1	$1.53M	Buy	+36,901	New	+$1.53M	0.51%	70

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Numerai's ATRC Position: Q2 2025 in Review

Numerai sold out of AtriCure (ATRC) in Q2 2025, closing a stake of 11,610 shares — an estimated $375K sold.

Numerai first reported a position in ATRC in Q1 2023 and held it in 2 quarters. The position peaked at $1.53M in Q1 2023. 201 funds tracked by Wall St. Rank hold ATRC as of Q2 2025.

Numerai reported no remaining AtriCure position as of Q2 2025 after selling out during the quarter.
Numerai sold 11,610 AtriCure shares in Q2 2025, an estimated $375K.
Numerai first reported a position in AtriCure in Q1 2023 and held it in 2 quarters.
Numerai's AtriCure position peaked at $1.53M in Q1 2023.
201 funds tracked by Wall St. Rank held AtriCure as of Q2 2025.

Based on Numerai's 13F filing for Q2 2025, filed 14 Aug 2025.